At, with and beyond risk: expectations of living with the possibility of future dementia
Author:
Affiliation:
1. Institute of Public Health; University of Cambridge; UK
2. Alzheimer Europe, Luxembourg
3. Erasmus MC; Rotterdam The Netherlands
4. Pasqual Maragall Foundation; Barcelona Spain
5. Imperial College; London UK
Funder
Innovative Medicines Initiative Joint Undertaking
Seventh Framework Programme
EFPIA
Alzheimer Society
Alabama Farmers Federation
Pasqual Maragall Foundation
“la Caixa” Foundation
Publisher
Wiley
Subject
Public Health, Environmental and Occupational Health,Health Policy,Health (social science)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1467-9566.12731/fullpdf
Reference78 articles.
1. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;Albert;Alzheimer's & Dementia,2011
2. The rise of surveillance medicine;Armstrong;Sociology of Health & Illness,1995
3. The converged experience of risk and disease;Aronowitz;The Milbank quarterly,2009
4. The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?;Arribas-Ayllon;British Medical Bulletin,2011
5. The practical ethics of genetic responsibility: non-disclosure and the autonomy of affect;Arribas-Ayllon;Social Theory & Health,2011
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility;Journal of Alzheimer's Disease;2024-01-30
2. Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol;Frontiers in Neurorobotics;2024-01-05
3. The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia;Brain Communications;2024
4. AI-Mind: Revolutionizing Personalized Neurology Through Automated Diagnostics and Advanced Data Management;Drug Repurposing;2024
5. Detecting value(s): Digital biomarkers for Alzheimer’s disease and the valuation of new diagnostic technologies;Sociology of Health & Illness;2023-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3